Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Sung Min Kim, Sukyoon Lee et al.|JAMA Neurology|2024Cited by 26
Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGADJae‐Won Hyun, Ho Jin Kim, Hye Lim Lee et al.|Multiple Sclerosis Journal|2021Cited by 22
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseasesJae‐Won Hyun, Ho Jin Kim, Hye Lim Lee et al.|Multiple Sclerosis Journal|2020Cited by 14
Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre studyKi Hoon Kim, Ho Jin Kim, Yeon Hak Chung et al.|Journal of Neurology Neurosurgery & Psychiatry|2024Cited by 8
Safety and Temporal Pattern of the Lymphocyte Count During Fingolimod Therapy in Patients With Multiple Sclerosis: Real-World Korean ExperienceSo‐Young Huh, Ho Jin Kim, Su‐Hyun Kim et al.|Journal of Clinical Neurology|2022Cited by 5